Correlation Between China SXT and Pacira BioSciences,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China SXT and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China SXT Pharmaceuticals and Pacira BioSciences,, you can compare the effects of market volatilities on China SXT and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Pacira BioSciences,.

Diversification Opportunities for China SXT and Pacira BioSciences,

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between China and Pacira is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of China SXT i.e., China SXT and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between China SXT and Pacira BioSciences,

Given the investment horizon of 90 days China SXT Pharmaceuticals is expected to under-perform the Pacira BioSciences,. In addition to that, China SXT is 1.95 times more volatile than Pacira BioSciences,. It trades about -0.03 of its total potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.25 per unit of volatility. If you would invest  1,637  in Pacira BioSciences, on September 15, 2024 and sell it today you would earn a total of  349.00  from holding Pacira BioSciences, or generate 21.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

China SXT Pharmaceuticals  vs.  Pacira BioSciences,

 Performance 
       Timeline  
China SXT Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Pacira BioSciences, 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

China SXT and Pacira BioSciences, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China SXT and Pacira BioSciences,

The main advantage of trading using opposite China SXT and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.
The idea behind China SXT Pharmaceuticals and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios